Adaptimmune Therapeutics
ADAP
#9324
Rank
S$89.32 M
Marketcap
$0.35
Share price
-20.31%
Change (1 day)
-81.22%
Change (1 year)

Market capitalization of Adaptimmune Therapeutics (ADAP)

Market cap: S$89.32 Million

As of April 2025 Adaptimmune Therapeutics has a market cap of S$89.32 Million. This makes Adaptimmune Therapeutics the world's 9324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptimmune Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025S$89.32 M-56.47%
2024S$0.20 B-13.73%
2023S$0.23 B-25.82%
2022S$0.32 B-59.51%
2021S$0.79 B-28.25%
2020S$1.10 B548.74%
2019S$0.17 B-79.29%
2018S$0.82 B-1.86%
2017S$0.83 B101.74%
2016S$0.41 B-65.64%
2015S$1.20 B

End of Day market cap according to different sources

On Apr 5th, 2025 the market cap of Adaptimmune Therapeutics was reported to be:

S$0.53 Billion
by Nasdaq info icon info icon
S$89.32 Million
by CompaniesMarketCap info icon info icon
S$89.32 Million
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$1.35 B 1,411.74%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.44 M-77.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.65 B 629.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$13.01 B 14,473.36%๐Ÿ‡บ๐Ÿ‡ธ USA